ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P ASX 200
7,700.30
-0.31%
S&P ASX All Technology
3,078.20
-0.47%
Brent Oil
82.16
0.04%
US Dollar vs AUD
1.51472
0.06%
Bitcoin
65,978.17
-1.00%
Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Get Started
  1. Home
  2. Investing
  3. ETFs
  4. Canada
  5. TSX
  6. iShares S&P TSX Canadian Preferred Share Index ETF (CPD)

  7. iShares S&P TSX Canadian Preferred Share Index ETF (CPD) News

CPD

iShares S&P TSX Canadian... (CPD)

iShares S&P TSX Canadian Preferred Share Index ETF
Date:
Sort by:
 Showing the most relevant articles for your search:TSX:CPD
DateTimeSourceHeadlineSymbolCompany
15/11/201221:00Marketwired CanadaCanadian Zinc Reports Financial and Operating Results for Third Quarter 2012TSX:CPDiShares S&P TSX Canadian Preferred Share Index ETF
16/05/201220:00Marketwired CanadaCanadian Zinc Reports Financial Results for First Quarter 2012TSX:CPDiShares S&P TSX Canadian Preferred Share Index ETF
29/01/201009:43PR Newswire (US)Caraco Pharmaceutical Laboratories, Ltd. Reports Results for the Third Quarter and First Nine Months of Fiscal Year 2010ASX:CPD
19/11/200902:20PR Newswire (US)Caraco Pharmaceutical Laboratories, Ltd. Markets Nicardipine Hydrochloride InjectionASX:CPD
07/11/200902:36PR Newswire (US)Caraco Pharmaceutical Laboratories, Ltd. Markets Generic Acular(R) Ophthalmic SolutionASX:CPD
07/11/200901:53PR Newswire (US)Caraco Pharmaceutical Laboratories, Ltd. Markets Generic Acular(R) Opthalmic SolutionASX:CPD
28/10/200902:59PR Newswire (US)/C O R R E C T I O N -- Caraco Pharmaceutical Laboratories, Ltd./ASX:CPD
28/10/200900:13PR Newswire (US)Caraco Pharmaceutical Laboratories, Ltd. Reports Results for the Second Quarter and First Six Months of Fiscal Year 2010ASX:CPD
02/10/200923:05PR Newswire (US)Caraco Pharmaceutical Laboratories, Ltd. Closes Asset Purchase Agreement with Forest Laboratories, Inc. to Settle Lexapro(R) (esASX:CPD
30/09/200906:01PR Newswire (US)Caraco Pharmaceutical Laboratories, Ltd. Enters Into Consent Decree with FDA Providing Path to Resume Manufacturing OperationsASX:CPD
24/09/200907:00PR Newswire (US)Caraco Pharmaceutical Laboratories, Ltd. Announces Resignation of Georges Ugeux from Board of DirectorsASX:CPD
15/09/200923:08PR Newswire (US)Caraco Pharmaceutical Laboratories, Ltd. Announces Appointment of F. Folsom Bell to Board of DirectorsASX:CPD
28/08/200900:34PR Newswire (US)Caraco Pharmaceutical Laboratories, Ltd. Announces Reversal of Summary Judgment in Ultracet(R) ANDA Patent LitigationASX:CPD
12/08/200908:37PR Newswire (US)Caraco Pharmaceutical Laboratories, Ltd. Markets Generic Imitrex(R) TabletsASX:CPD
03/08/200914:22PR Newswire (US)Caraco Pharmaceutical Laboratories, Ltd. Announces Settlement of Ethyol(R) ANDA Patent LitigationASX:CPD
29/07/200909:30PR Newswire (US)Caraco Pharmaceutical Laboratories, Ltd. Announces Change to Executive Team as Jitendra N. Doshi Assumes Position of CEOASX:CPD
29/07/200906:42PR Newswire (US)Caraco Pharmaceutical Laboratories, Ltd. Reports Results for the First Quarter of Fiscal Year 2010ASX:CPD
24/07/200909:01PR Newswire (US)Caraco Pharmaceutical Laboratories, Ltd. Announces Filing of Purported Class Action LawsuitsASX:CPD
10/07/200923:15PR Newswire (US)Caraco Pharmaceutical Laboratories, Ltd. Enters Into Asset Purchase Agreement with Forest Laboratories, Inc. to Settle Lexapro(RASX:CPD
08/07/200901:44PR Newswire (US)Caraco Pharmaceutical Laboratories, Ltd. Markets Generic Casodex(R) TabletsASX:CPD
06/07/200923:04PR Newswire (US)Caraco Pharmaceutical Laboratories, Ltd. Announces an Indefinite Reduction in its WorkforceASX:CPD
26/06/200923:15PR Newswire (US)Caraco Pharmaceutical Laboratories, Ltd. Updates on Financial PositionASX:CPD
26/06/200912:09PR Newswire (US)Caraco Pharmaceutical Laboratories, Ltd. Announces FDA ActionASX:CPD
29/05/200909:51PR Newswire (US)Caraco Pharmaceutical Laboratories, Ltd. Reports Results for the Fiscal Year 2009, Updates on FDA InspectionASX:CPD
15/05/200900:24PR Newswire (US)Caraco Pharmaceutical Laboratories, Ltd. Markets Generic Roxicodone(R) TabletsASX:CPD
03/04/200901:03PR Newswire (US)Caraco Pharmaceutical Laboratories, Ltd. Markets Generic Topamax(R) TabletsASX:CPD
01/04/200905:50PR Newswire (US)Caraco Pharmaceutical Laboratories, Ltd. Announces a Nationwide Voluntary Recall of All Lots of Digoxin Tablets Due to Size VariASX:CPD
30/01/200902:41PR Newswire (US)Caraco Pharmaceutical Laboratories, Ltd. Reports Results for the Third Quarter and First Nine Months of Fiscal 2009ASX:CPD
23/01/200901:24PR Newswire (US)Caraco Pharmaceutical Laboratories, Ltd. to Announce Third Quarter of Fiscal Year 2009 Results on January 29, 2009ASX:CPD
25/11/200812:00PR Newswire (US)Caraco Pharmaceutical Laboratories, Ltd. Responds to FDA Warning LetterASX:CPD
 Showing the most relevant articles for your search:TSX:CPD

Your Recent History

ASX
WDC
Westfield
ASX
MQG
Macquarie
SPI
SP500
S&P 500
ASX
XAO
Australian SE All Ordina...
FTSE
UKX
FTSE 100
ASX
QBE
QBE Insurance
NYSE
NKE
Nike
ASX
RIO
Rio Tinto
NYSE
MRK
Merck
ASX
WBC
Westpac Banking
ASX
CSL
CSL
ASX
ANZ
Australia And New Zealan...
NASDAQ
AMZN
Amazon.com
NYSE
DIS
Walt Disney
NASDAQ
QQQ
Invesco QQQ Trust Series 1
ASX
CBA
Commonwealth Bank Of Aus...
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Australia
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved